2026 Interim report
Filed with HKEX · Stock code 2566 · · 48 pages · English
2 Defi nitions 6 Corporate Information 8 Financial Summary 9 Management Discussion and Analysis 17 Corporate Governance and Other Information 26 Interim Condensed Consolidated Statement of Profi t or Loss and Other Comprehensive Income 27 Interim Condensed Consolidated Statement of Financial Position 29 Interim Condensed Consolidated Statement of Changes in Equity 30 Interim Condensed Consolidated
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. on 6ix
Earlier from Hangzhou Jiuyuan Genetic Biopharmaceutical
- Articles of association
- Poll results of the first extraordinary general meeting of 2026 held on Friday, September 18, 2026
- Next Day Disclosure Returns
- (Revised) Next Day Disclosure Returns
- List of directors and their roles and functions
Later from Hangzhou Jiuyuan Genetic Biopharmaceutical
All Hangzhou Jiuyuan Genetic Biopharmaceutical news releasesFollow Hangzhou Jiuyuan Genetic Biopharmaceutical into a list and get an email when it puts out news.
Follow Hangzhou Jiuyuan Genetic Biopharmaceutical